Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 27;14(5):923–943. doi: 10.4254/wjh.v14.i5.923

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

PMC Copyright notice

A 57-year-old male underwent abdominal computed tomography scan with contrast for the evaluation of a renal mass demonstrating a hepatic lesion in S3, hypodense on contrast-enhanced computed tomography. Liver magnetic resonance imaging (MRI) confirmed the presence of a nodule hypointense on T1-weighted sequences, slightly hyperintense on long TR sequences, without significant restriction on the ADC map. During dynamic study after intravenous contrast injection (gadoxetic acid), the lesion does not have significant enhancement and it appears hypointense on the hepatobiliary phase. At 11 mo follow-up, the nodule shows stable dimensions and MRI signal features. These features are consistent with fibrous hemangioma. A: Arterial phase of liver computed tomography (CT); B: In-phase T1-weighted image; C: T2-Spectral Attenuated Inversion Recovery; D: Portal venous phase of liver CT; E: Out-of-phase T1-weighted image; F: ADC map; G: Delayed phase of liver CT; H: T2-weighted image; I: Hepatobiliary phase (HBP) magnetic resonance imaging (MRI); J: T2-Spectral Attenuated Inversion Recovery; K: ADC map; L: HBP MRI.